{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:07:18Z","timestamp":1770977238672,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bioorg.2026.109567","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:25:05Z","timestamp":1769559905000},"page":"109567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adenine nucleotides as potent and selective GPR17 modulators"],"prefix":"10.1016","volume":"171","author":[{"given":"Diego","family":"Dal Ben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia","family":"Lambertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Buccioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Francucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Spinaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Volpini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109567_bb0005","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2026.109567_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003579","article-title":"The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair","volume":"3","author":"Lecca","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.109567_bb0015","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/cmdc.201600453","article-title":"The G protein-coupled receptor GPR17: overview and update","volume":"11","author":"Marucci","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109567_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176762","article-title":"Role of orphan G-protein coupled receptors in tissue ischemia: a comprehensive review","volume":"978","author":"Keifi Bajestani","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0025","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109567_bb0030","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/glia.21107","article-title":"Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death","volume":"59","author":"Ceruti","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.bioorg.2026.109567_bb0040","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/glia.21237","article-title":"The GPR17 receptor in NG2 expressing cells: focus on in vivo cell maturation and participation in acute trauma and chronic damage","volume":"59","author":"Boda","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.bioorg.2026.109567_bb0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11302-013-9366-3","article-title":"Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury","volume":"9","author":"Franke","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2026.109567_bb0050","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/brain\/awp147","article-title":"The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury","volume":"132","author":"Ceruti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bioorg.2026.109567_bb0055","doi-asserted-by":"crossref","first-page":"ra93","DOI":"10.1126\/scisignal.2004350","article-title":"Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist","volume":"6","author":"Hennen","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2026.109567_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jlb.59.1.18","article-title":"New members of the chemokine receptor gene family","volume":"59","author":"Raport","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00001756-200203250-00008","article-title":"BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells","volume":"13","author":"Basrai","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.bioorg.2026.109567_bb0070","first-page":"C1028","article-title":"Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells","volume":"297","author":"Pugliese","year":"2009","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.bioorg.2026.109567_bb0075","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1476-5381.2009.00633.x","article-title":"Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants","volume":"159","author":"Benned-Jensen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.M115.683953","article-title":"The orphan G protein-coupled receptor GPR17 negatively regulates oligodendrocyte differentiation via Galphai\/o and its downstream effector molecules","volume":"291","author":"Simon","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0085","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/glia.23807","article-title":"Regulation and signaling of the GPR17 receptor in oligodendroglial cells","volume":"68","author":"Lecca","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.bioorg.2026.109567_bb0090","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tips.2025.05.001","article-title":"GPR17 - orphan G protein-coupled receptor with therapeutic potential","volume":"46","author":"Lewash","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109567_bb0095","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1021\/jm901691y","article-title":"Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor","volume":"53","author":"Calleri","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0100","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","article-title":"GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4","volume":"106","author":"Maekawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.109567_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.113.207647","article-title":"Is GPR17 a P2Y\/leukotriene receptor? Examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17","volume":"347","author":"Qi","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2026.109567_bb0110","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0115","series-title":"Methods of Identifying Modulators of gpr17, US8404436B1","author":"Kostenis","year":"2013"},{"key":"10.1016\/j.bioorg.2026.109567_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1039\/C3MD00309D","article-title":"Improved synthesis of 4\u2212\/6-substituted 2-carboxy-1H-indole-3-propionic acid derivatives and structure\u2013activity relationships as GPR17 agonists","volume":"5","author":"Baqi","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2026.109567_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111789","article-title":"Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17","volume":"186","author":"Pillaiyar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231483","article-title":"Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: a novel disease-modifying strategy for multiple sclerosis","volume":"15","author":"Parravicini","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.109567_bb0135","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1021\/acs.jmedchem.1c00277","article-title":"Synthesis and preclinical validation of novel indole derivatives as a GPR17 agonist for glioblastoma treatment","volume":"64","author":"Nguyen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bph.15969","article-title":"Identification and characterization of select oxysterols as ligands for GPR17","volume":"180","author":"Harrington","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0145","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1021\/acs.jmedchem.4c01755","article-title":"Discovery of Anthranilic acid derivatives as antagonists of the pro-inflammatory orphan G protein-coupled receptor GPR17","author":"Boshta","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.159","article-title":"Cryo-EM structure of G-protein-coupled receptor GPR17 in complex with inhibitory G protein","volume":"3","author":"Ye","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.109567_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13543776.2019.1568990","article-title":"GPR17 receptor modulators and their therapeutic implications: review of recent patents","volume":"29","author":"Marucci","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2026.109567_bb0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11302-011-9245-8","article-title":"Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17","volume":"7","author":"Buccioni","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bioorg.2026.109567_bb0165","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1021\/jm100030u","article-title":"2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure","volume":"53","author":"Eliahu","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0170","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-1982-29896","article-title":"Modification of nucleic acid bases via radical intermediates: synthesis of Dihalogenated purine nucleosides","volume":"1982","author":"Nair","year":"1982","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2026.109567_bb0175","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/jm1016297","article-title":"Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors","volume":"54","author":"El-Tayeb","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0040-4020(01)90496-X","article-title":"Synthetic approaches to new doubly modified nucleosides: congeners of cordycepin and related 2\u2032-deoxyadenosine","volume":"47","author":"Nair","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109567_bb0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1021\/cb8000414","article-title":"Novel genetically encoded biosensors using firefly luciferase","volume":"3","author":"Fan","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.copbio.2009.02.013","article-title":"Engineered luciferases for molecular sensing in living cells","volume":"20","author":"Binkowski","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0195","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/jm061222w","article-title":"Structure-activity relationship of uridine 5\u2032-diphosphoglucose analogues as agonists of the human P2Y14 receptor","volume":"50","author":"Ko","year":"2007","journal-title":"J. Med. Chem."},{"issue":"7498","key":"10.1016\/j.bioorg.2026.109567_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature13288","article-title":"Agonist-bound structure of the human P2Y12 receptor","volume":"509","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109567_bb0205","series-title":"1255 University St., Suite 1600, Montreal, Quebec, Canada, H3B 3X3","author":"Molecular Operating Environment, C.C.G., Inc","year":"2026"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109567_bb0210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109567_bb0215","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood-brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109567_bb0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:12:08Z","timestamp":1770973928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S0045206826001033"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109567","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenine nucleotides as potent and selective GPR17 modulators","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109567"}}